ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From
ScripAlmost as soon as COVID-19 vaccines became available, their recipients became either “Team Pfizer” or “Team Moderna,” while competing products from AstraZeneca PLC and Johnson & Johnson quickly fe
ScripChinese developers of COVID-19 antivirals and vaccines are diverging on whether to stay in the game, underscored by mixed first-half progress against the mutating SARS-CoV-2 virus. The Omicron subvari
Pink SheetJust when everyone was expecting something significant to happen, China has now disclosed a new set of 10 rules to further ease its draconian "COVID Zero" policies. Part of the new approach, which fol